---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-167332"
form_type: "8-K"
ticker: "SPRB"
cik: "0001683553"
company_name: "SPRUCE BIOSCIENCES, INC."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:54:23.852490+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Spruce Biosciences prices $69M public offering of common stock and pre-funded warrants

## Summary
- Gross proceeds ~$69M from 1.33M shares at $50/share and 50K pre-funded warrants at $49.99.
- Underwriters' option for 180K additional shares exercised in full on April 21, 2026.
- Offering expected to close April 22; net proceeds for working capital and general corporate purposes.
- Pre-funded warrants exercisable immediately at $0.01 per share, with a 4.99% beneficial ownership cap.

## SEC filing metadata
- accession: 0001193125-26-167332
- form_type: 8-K
- ticker: SPRB
- cik: 0001683553
- company_name: SPRUCE BIOSCIENCES, INC.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1683553/000119312526167332/0001193125-26-167332-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1683553/000119312526167332/sprb-20260420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-167332
- JSON: https://secwatch.observer/filing/0001193125-26-167332.json
- Plain text: https://secwatch.observer/filing/0001193125-26-167332.txt

## Source-grounded claims
- claim_id: 2fd8fdcfca1e0987a2c393b0716f65a4b3ccef3a
  claim: SPRUCE BIOSCIENCES, INC. entered into Underwriting Agreement with Leerink Partners LLC, Guggenheim Securities, LLC and Oppenheimer & Co. Inc. valued at $69.0 million (effective 2026-04-20).
  evidence_excerpt: On April 20, 2026, Spruce Biosciences, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC, Guggenheim Securities, LLC and Oppenheimer & Co. Inc., as representatives of the several underwriters listed therein
  evidence_url: https://www.sec.gov/Archives/edgar/data/1683553/000119312526167332/0001193125-26-167332-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.